Converge Bio
Other Information Technology
Converge Bio valuation and funding history | Last updated: January 13, 2026 | 1 funding rounds
Current Valuation
N/A
As of January 13, 2026
Total Funding Raised
N/A
Across 1 round
Last Round
Early Stage VC (Series A)
$25.0M
Last Funding
Jan 2026
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| January 13, 2026 | Early Stage VC (Series A) | $25.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Converge Bio is currently valued at N/A as of January 13, 2026.
What is Converge Bio Worth in 2026?
Converge Bio is a leading private company in the Other Information Technology sector. Track Converge Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Converge Bio Valuation is Determined
Private company valuations like Converge Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.